We’re tracking in-house compensation. Take the Law360 Survey
Click here
February 17, 2022
Davis v. Natera, Inc.
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
February 18, 2022
Genetic-screening company Natera Inc. knowingly sold and marketed unreliable prenatal tests to doctors and pregnant women that incorrectly indicated healthy fetuses had serious birth defects, sometimes leading to abortions, according to a proposed class action filed in California federal court Thursday.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Get instant access to the one-stop news source for business lawyers
Register Now!
Sign up now for free access to this content